Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lineage, Inc. (LINE)
:LINE
Holding LINE?
Track your performance easily
LINE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$52.75 - $89.85
Previous CloseN/A
Volume237.08K
Average Volume (3M)1.03M
Market Cap
$13.11B
Enterprise Value$24.28B
Total Cash (Recent Filing)$68.20M
Total Debt (Recent Filing)$10.95B
Price to Earnings (P/E)―
Beta0.18
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Dec 31, 2024Dividend Yield1.67%
Share Statistics
EPS (TTM)N/A
Shares Outstanding228,411,730
10 Day Avg. Volume831,213
30 Day Avg. Volume1,033,665
Standard Deviation0.04
R-Squared0.45
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.11
Price to Cash Flow (P/CF)16.70
P/FCF Ratio0.00
Enterprise Value/Market Cap1.85
Enterprise Value/Revenue9.12
Enterprise Value/Gross Profit13.86
Enterprise Value/Ebitda-459.92
Forecast
1Y Price Target
$76.64Price Target Upside33.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Lineage, Inc. News
Bulls Say, Bears Say
Bulls Say
AcquisitionsLINE's portfolio scale and cost of capital will allow the company to source accretive acquisitions to help offset some of the growth headwinds.
Analyst RecommendationAnalyst reiterates 'Overweight' and 'Top pick' for the stock with a price target of $100.
Financial PerformanceLineage Inc. reported a notable beat in AFFO for the third quarter, surpassing consensus estimates by 17%.
Bears Say
Industry ChallengesThe industry is facing headwinds as customers rationalize inventories.
Job CutsInvestors are interpreting job cuts as a potential reaction to sagging top line growth.
Pricing ConcernsPricing power was weaker at -0.9% year-over-year versus the expected +1.0%.
---
LINE FAQ
What was Lineage, Inc.’s price range in the past 12 months?
Lineage, Inc. lowest stock price was $52.75 and its highest was $89.85 in the past 12 months.
What is Lineage, Inc.’s market cap?
Lineage, Inc.’s market cap is $13.11B.
When is Lineage, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lineage, Inc.’s earnings last quarter?
Lineage, Inc. released its earnings results on Nov 06, 2024. The company reported -$2.44 earnings per share for the quarter, missing the consensus estimate of -$1.633 by -$0.807.
Is Lineage, Inc. overvalued?
According to Wall Street analysts Lineage, Inc.’s price is currently Undervalued.
Does Lineage, Inc. pay dividends?
Lineage, Inc. pays a Notavailable dividend of $0.906 which represents an annual dividend yield of 1.67%. See more information on Lineage, Inc. dividends here
What is Lineage, Inc.’s EPS estimate?
Lineage, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lineage, Inc. have?
Lineage, Inc. has 228,411,730 shares outstanding.
What happened to Lineage, Inc.’s price movement after its last earnings report?
Lineage, Inc. reported an EPS of -$2.44 in its last earnings report, missing expectations of -$1.633. Following the earnings report the stock price went down -7.35%.
Which hedge fund is a major shareholder of Lineage, Inc.?
Currently, no hedge funds are holding shares in LINE
---
Lineage, Inc. Stock Smart Score
Company Description
Lineage, Inc.
Lineage, Inc. is the worlds largest global temperature-controlled warehouse REIT with a large network of strategically located facilities across countries in North America, Europe, and Asia-Pacific. Coupling end-to-end supply chain solutions and technology, Lineage partners with some of the worlds largest food and beverage producers, retailers, and distributors to help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, feed the world.
---
LINE Company Deck
---
LINE Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presents a strong financial performance and strategic achievements, particularly the successful IPO and continued growth through acquisitions. However, it also highlights challenges, including occupancy and demand pressures, and impacts from a facility fire. The company remains well-positioned with strategic plans to navigate these issues.Read More>---
LINE Stock 12 Month Forecast
Average Price Target
$76.64
▲(33.50% Upside)
Technical Analysis
Sangamo Biosciences
―
Bluebird Bio
―
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Best Analysts Covering LINE
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-19.70%
reiterated a buy rating last month
Copying Ki Bin Kim's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -19.70% per trade.
---